An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 204587
Company: HETERO LABS LTD III

Products on ANDA 204587

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
RITONAVIR	RITONAVIR	100MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 204587

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/17/2018	ORIG-1	Approval				Label is not available on this site.

Therapeutic Equivalents for ANDA 204587

RITONAVIR

TABLET;ORAL; 100MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
NORVIR	RITONAVIR	100MG	TABLET;ORAL	Prescription	Yes	AB	022417	ABBVIE
RITONAVIR	RITONAVIR	100MG	TABLET;ORAL	Prescription	No	AB	206614	AUROBINDO PHARMA LTD
RITONAVIR	RITONAVIR	100MG	TABLET;ORAL	Prescription	No	AB	202573	CIPLA
RITONAVIR	RITONAVIR	100MG	TABLET;ORAL	Prescription	No	AB	203759	CIPLA
RITONAVIR	RITONAVIR	100MG	TABLET;ORAL	Prescription	No	AB	204587	HETERO LABS LTD III

Top